Publication

Medications for obesity as preventatives: a public and patient safety issue

Flint, Stuart W
; 
Brown, Adrian
; 
Vázquez-Velázquez, Verónica
; 
Hazlehurst, Jonathan M
Abstract
No abstract available
MIDER Authors
Hazlehurst, Jonathan
Citations
Altmetric:
Date
2024-11-26
Type
Correspondence
Subject
Diseases & disorders of systemic, metabolic or environmental origin, Biochemistry, Public health. Health statistics. Occupational health. Health education, Endocrinology
Collections
UHB Diabetes and Endocrinology
Show all metadata
Citation
Flint SW, Brown A, Vázquez-Velázquez V, Hazlehurst JM. Medications for obesity as preventatives: a public and patient safety issue. Lancet Diabetes Endocrinol. 2024 Dec;12(12):878-879. doi: 10.1016/S2213-8587(24)00319-X.
Journal / Source Title
The Lancet Diabetes & Endocrinology
DOI
10.1016/S2213-8587(24)00319-X
URI
http://hdl.handle.net/20.500.14200/6838
PMID
39608962
Publisher
The Lancet, Diabetes & Endocrinology
Publisher’s URL
https://www.thelancet.com/journals/landia/home
Publisher’s statement
Note / Copyright